Feeds

Sony pumps cash into gene-wrangling joint venture

Electronics outfit thinks the future is wetware and wants in before the rush

The Essential Guide to IT Transformation

PlayStation purveyor Sony wants to be remembered for more than overpriced electronics and massive data breaches, having just launched a joint venture in the field of genome research.

The electronics giant has teamed up with medical firm M3, in which Sony is already the majority investor, and US biz Illumina, which makes genome-sequencing gear.

The new venture, named P5, will build a “genome information platform” business to sell genome analysis services to research institutions and enterprises in Japan, according to Sony.

It’s also interested in combining genome data with other medical data to support advancements in personalised healthcare, a field imagined to one day offer medical treatments optimised for individuals.

“We aim to facilitate genome research that further advances Japanese medical care, and in the future establish a new service platform for the medical industry," said Tadashi Saito, head of Sony’s medical biz, in a canned statement.

M3 director Itaru Tanimaru was even bolder, claiming that gene diagnosis and treatment could have a greater impact on lives than the internet.

“The current status of the human genome industry is comparable to the internet in the early 1990's, when companies such as Google, Amazon and Facebook had yet to emerge,” he added.

“Going forward, I expect companies and services of this magnitude to also appear in this industry. This three party alliance combines each company's unique strengths and resources, and together we intend to build a service platform that could not have been realised by others.”

Sony CEO Kazuo Hirai has already shown he intends to make the firm’s medical business a major part of its future.

Back in 2012 it invested ¥50bn ($642m) to take a ten per cent stake in ailing digital camera company Olympus, with which it plans to develop new medical equipment. ®

Boost IT visibility and business value

More from The Register

next story
iPad? More like iFAD: We reveal why Apple fell into IBM's arms
But never fear fanbois, you're still lapping up iPhones, Macs
Sonos AXES support for Apple's iOS4 and 5
Want to use your iThing? You can't - it's too old
Amazon says Hachette should lower ebook prices, pay authors more
Oh yeah ... and a 30% cut for Amazon to seal the deal
Philip K Dick 'Nazi alternate reality' story to be made into TV series
Amazon Studios, Ridley Scott firm to produce The Man in the High Castle
Too many IT conferences to cover? MICROSOFT to the RESCUE!
Yet more word of cuts emerges from Redmond
Joe Average isn't worth $10 a year to Mark Zuckerberg
The Social Network deflates the PC resurgence with mobile-only usage prediction
Chips are down at Broadcom: Thousands of workers laid off
Cellphone baseband device biz shuttered
Feel free to BONK on the TUBE, says Transport for London
Plus: Almost NOBODY uses pay-by-bonk on buses - Visa
Twitch rich as Google flicks $1bn hitch switch, claims snitch
Gameplay streaming biz and search king refuse to deny fresh gobble rumors
prev story

Whitepapers

Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Consolidation: The Foundation for IT Business Transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.
Backing up Big Data
Solving backup challenges and “protect everything from everywhere,” as we move into the era of big data management and the adoption of BYOD.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Why and how to choose the right cloud vendor
The benefits of cloud-based storage in your processes. Eliminate onsite, disk-based backup and archiving in favor of cloud-based data protection.